Sanofi (SNY) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $40.61, +0.79% vs the prior close of $40.29.
- Volume 4.63M shares, 1.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SNY rises 0.8% to $40.61, 3 up days in a row. Closed at $40.61, +0.79% vs the prior close of $40.29. Day range $40.16–$40.61, opened at $40.37.
SNY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SNY rises 0.8% to $40.61, 3 up days in a row
- Closed at $40.61, +0.79% vs the prior close of $40.29. Day range $40.16–$40.61, opened at $40.37.
- Volume was 4.63M shares, 1.7x its 50-day average of 2.80M.
- Price is -4.8% vs its 50-day average ($42.67) and -9.0% vs its 200-day average ($44.63).
- 52-week range $39.07–$52.68; today's close sits at 11% of that range, 22.9% below the 52-week high.
- That makes 3 straight gains.
Oct 15, 2026 — SNY rises 1.3% to $40.29 on 1.8x normal volume
- Closed at $40.29, +1.31% vs the prior close of $39.77. Day range $40.17–$40.87, opened at $40.64.
- Volume was 5.05M shares, 1.8x its 50-day average of 2.75M — unusually heavy trading.
- Price is -5.7% vs its 50-day average ($42.72) and -9.8% vs its 200-day average ($44.67).
- 52-week range $39.07–$52.68; today's close sits at 9% of that range, 23.5% below the 52-week high.
Oct 14, 2026 — SNY rises 1.7% to $39.77 on 2.0x normal volume
- Closed at $39.77, +1.66% vs the prior close of $39.12. Day range $39.33–$40.00, opened at $39.37.
- Volume was 5.34M shares, 2.0x its 50-day average of 2.69M — unusually heavy trading.
- Price is -7.0% vs its 50-day average ($42.77) and -11.1% vs its 200-day average ($44.71).
- 52-week range $39.07–$52.68; today's close sits at 5% of that range, 24.5% below the 52-week high.
Oct 13, 2026 — SNY dips 1.6% to $39.12, a 52-week low, 3 down days in a row
- Closed at $39.12, -1.56% vs the prior close of $39.74. Day range $39.07–$40.12, opened at $40.12.
- Volume was 3.99M shares, 1.5x its 50-day average of 2.66M.
- Price is -8.6% vs its 50-day average ($42.82) and -12.6% vs its 200-day average ($44.76).
- 52-week range $39.07–$52.68; today's close sits at 0% of that range, 25.7% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — SNY dips 0.8% to $39.74
- Closed at $39.74, -0.82% vs the prior close of $40.07. Day range $39.69–$40.32, opened at $40.24.
- Volume was 2.94M shares, 1.1x its 50-day average of 2.66M.
- Price is -7.4% vs its 50-day average ($42.90) and -11.3% vs its 200-day average ($44.80).
- 52-week range $39.18–$52.68; today's close sits at 4% of that range, 24.6% below the 52-week high.
Oct 9, 2026 — SNY dips 0.4% to $40.07
- Closed at $40.07, -0.40% vs the prior close of $40.23. Day range $39.92–$40.31, opened at $40.17.
- Volume was 2.10M shares, 0.7x its 50-day average of 2.83M.
- Price is -6.7% vs its 50-day average ($42.97) and -10.7% vs its 200-day average ($44.85).
- 52-week range $39.18–$52.68; today's close sits at 7% of that range, 23.9% below the 52-week high.
Oct 8, 2026 — SNY ends flat (+0.1%) to $40.23, 3 up days in a row
- Closed at $40.23, +0.07% vs the prior close of $40.20. Day range $39.58–$40.27, opened at $40.18.
- Volume was 3.00M shares, 1.1x its 50-day average of 2.84M.
- Price is -6.5% vs its 50-day average ($43.02) and -10.4% vs its 200-day average ($44.89).
- 52-week range $39.18–$52.68; today's close sits at 8% of that range, 23.6% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — SNY rises 1.6% to $40.20
- Closed at $40.20, +1.62% vs the prior close of $39.56. Day range $39.72–$40.25, opened at $39.94.
- Volume was 2.08M shares, 0.7x its 50-day average of 2.85M.
- Price is -6.8% vs its 50-day average ($43.12) and -10.5% vs its 200-day average ($44.93).
- 52-week range $39.18–$52.68; today's close sits at 8% of that range, 23.7% below the 52-week high.
Oct 6, 2026 — SNY ends flat (+0.1%) to $39.56
- Closed at $39.56, +0.13% vs the prior close of $39.51. Day range $39.24–$40.05, opened at $40.05.
- Volume was 3.05M shares, 1.1x its 50-day average of 2.85M.
- Price is -8.5% vs its 50-day average ($43.22) and -12.0% vs its 200-day average ($44.97).
- 52-week range $39.18–$52.68; today's close sits at 3% of that range, 24.9% below the 52-week high.
Oct 5, 2026 — SNY dips 1.0% to $39.51, a 52-week low, 3 down days in a row
- Closed at $39.51, -1.03% vs the prior close of $39.92. Day range $39.18–$39.88, opened at $39.83.
- Volume was 3.80M shares, 1.3x its 50-day average of 2.84M.
- Price is -8.8% vs its 50-day average ($43.31) and -12.2% vs its 200-day average ($45.01).
- 52-week range $39.18–$52.68; today's close sits at 2% of that range, 25.0% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — SNY dips 1.8% to $39.92, a 52-week low
- Closed at $39.92, -1.84% vs the prior close of $40.67. Day range $39.50–$40.07, opened at $39.58.
- Volume was 4.33M shares, 1.6x its 50-day average of 2.79M.
- Price is -8.0% vs its 50-day average ($43.39) and -11.4% vs its 200-day average ($45.05).
- 52-week range $39.50–$52.68; today's close sits at 3% of that range, 24.2% below the 52-week high.
SNY latest news & SEC filings
Every SEC filing by or about SNY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 25, 2026 · Form N-PX — Annual proxy voting record
Annual proxy voting record
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 4, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 28, 2026 · Form 13F-HR — Quarterly holdings report filed by an institutional investment manager
Quarterly holdings report filed by an institutional investment manager
Jul 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 22, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade SNY
- How much it moves: over the last 20 sessions the average daily move was 0.96% (largest 2.0%). That is a relatively calm stock.
- Liquidity: about 3.56M shares (≈$144.60M) trade per day on average.
- 52-week position: $40.61 vs a range of $39.07–$52.68 (11% of the range).
- Dividends: last ex-dividend date May 4, 2026 ($2.422/share); 1 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 1, 2026; 6-K Sep 17, 2026; 6-K Aug 6, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SNY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 40.37 | 40.61 | 40.16 | 40.61 | 4.63M |
| Oct 15, 2026 | 40.64 | 40.87 | 40.17 | 40.29 | 5.05M |
| Oct 14, 2026 | 39.37 | 40.00 | 39.33 | 39.77 | 5.34M |
| Oct 13, 2026 | 40.12 | 40.12 | 39.07 | 39.12 | 3.99M |
| Oct 12, 2026 | 40.24 | 40.32 | 39.69 | 39.74 | 2.94M |
| Oct 9, 2026 | 40.17 | 40.31 | 39.92 | 40.07 | 2.10M |
| Oct 8, 2026 | 40.18 | 40.27 | 39.58 | 40.23 | 3.00M |
| Oct 7, 2026 | 39.94 | 40.25 | 39.72 | 40.20 | 2.08M |
| Oct 6, 2026 | 40.05 | 40.05 | 39.24 | 39.56 | 3.05M |
| Oct 5, 2026 | 39.83 | 39.88 | 39.18 | 39.51 | 3.80M |
| Oct 2, 2026 | 39.58 | 40.07 | 39.50 | 39.92 | 4.33M |
| Oct 1, 2026 | 41.85 | 41.88 | 40.64 | 40.67 | 6.68M |
| Sep 30, 2026 | 41.35 | 41.38 | 40.96 | 41.23 | 4.30M |
| Sep 29, 2026 | 40.58 | 40.80 | 40.40 | 40.74 | 3.04M |
| Sep 28, 2026 | 40.77 | 41.24 | 40.77 | 41.18 | 2.17M |
| Sep 25, 2026 | 40.89 | 41.12 | 40.66 | 41.11 | 2.22M |
| Sep 24, 2026 | 41.23 | 41.61 | 40.91 | 40.94 | 3.07M |
| Sep 23, 2026 | 41.85 | 41.96 | 41.41 | 41.66 | 3.84M |
| Sep 22, 2026 | 42.34 | 42.62 | 42.03 | 42.51 | 3.08M |
| Sep 21, 2026 | 42.64 | 42.78 | 42.47 | 42.50 | 2.48M |
About Sanofi
Sanofi (SNY) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in PARIS, France. State of incorporation: France. Fiscal year ends December 31. SEC CIK 1121404.
SNY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SNY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
SNY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SNY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.